TerminatedNCT04280354

Molecular Biomarkers for Sepsis

Studying Syringocystadenoma papilliferum

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University Hospital, Basel, Switzerland
Principal Investigator: Adrian Egli, PD Dr.
Clinical Microbiology, University Hospital Basel
Intervention: compare data patterns by data-driven algorithms to determine sepsis(other)
Enrollment: 3 target
Eligibility: 18 years · All sexes
Timeline: 2022 – 2022

Study locations (15)

Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland
Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
Intensive Care Unit; University Hospital Basel, Basel, Switzerland
Institute for Infectious Diseases, University of Bern, Bern, Switzerland
Infectious Diseases and Hospital Epidemiology, University Hospital Bern, Bern, Switzerland
Intensive Care Unit, University Hospital Bern, Bern, Switzerland
Clinical Bacteriology, University Hospital Geneva, Geneva, Switzerland
Infectious Diseases and Hospital Epidemiology, University Hospital Geneva, Geneva, Switzerland
Intensive Care Unit, University Hospital Geneva, Geneva, Switzerland
Clinical Microbiology, University Hospital Lausanne, Lausanne, Switzerland
Infectious Diseases and Hospital Epidemiology , University Hospital Lausanne, Lausanne, Switzerland
Intensive Care Unit, University Hospital Lausanne, Lausanne, Switzerland
Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland
Institute for Medical Microbiology, University Hospital Zurich, Zurich, Switzerland
Intensive Care Unit, University Hospital Zurich, Zurich, Switzerland

Collaborators

Swiss Personalized Health Network (SPHN) · Personalized Health and Related Technologies (PHRT) initiative of ETH Zürich

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04280354 on ClinicalTrials.gov

Other trials for Syringocystadenoma papilliferum

Additional recruiting or active studies for the same condition.

See all trials for Syringocystadenoma papilliferum →

← Back to all trials